Vanta Bioscience Limited Share Price
Equities
VANTABIO6
INE695X01011
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
69.45 INR | +4.99% | +15.19% | +29.69% |
04-03 | Vanta Bioscience Bags INR12 Million Order to Conduct Technical Studies | MT |
04-02 | Vanta Bioscience Limited Receives an Order of INR 12 Million from A Large Indian Multinational Company | CI |
Sales 2022 | 100M 1.2M 96.19M | Sales 2023 | 68.95M 826K 66.2M | Capitalization | 363M 4.35M 348M |
---|---|---|---|---|---|
Net income 2022 | - 0 0 | Net income 2023 | -64M -767K -61.45M | EV / Sales 2022 | 11.4 x |
Net Debt 2022 | 446M 5.35M 429M | Net Debt 2023 | 571M 6.84M 548M | EV / Sales 2023 | 13.5 x |
P/E ratio 2022 |
786
x | P/E ratio 2023 |
-5.6
x | Employees | 47 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 28.14% |
1 day | +4.99% | ||
1 week | +15.19% | ||
Current month | +8.52% | ||
1 month | +8.52% | ||
3 months | +19.74% | ||
6 months | +66.15% | ||
Current year | +29.69% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 37 | 28/04/16 | |
Director of Finance/CFO | - | 10/11/21 | |
Chief Tech/Sci/R&D Officer | 64 | 03/01/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 64 | 28/04/16 | |
Chief Executive Officer | 37 | 28/04/16 | |
Chief Tech/Sci/R&D Officer | 64 | 03/01/17 |
Date | Price | Change | Volume |
---|---|---|---|
30/04/24 | 69.45 | +4.99% | 5,250 |
29/04/24 | 66.15 | +5.00% | 4,500 |
26/04/24 | 63 | +2.42% | 5,250 |
24/04/24 | 61.51 | -2.83% | 7,500 |
23/04/24 | 63.3 | +4.99% | 3,750 |
Delayed Quote Bombay S.E., April 30, 2024 at 11:00 am
More quotes1st Jan change | Capi. | |
---|---|---|
+29.69% | 5M | |
+0.17% | 42.86B | |
+10.92% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+5.23% | 25.15B | |
-24.79% | 18.63B | |
+26.69% | 12.37B | |
-3.13% | 11.92B | |
+6.57% | 11.21B |
- Stock Market
- Equities
- VANTABIO6 Stock